vs
Bionano Genomics, Inc.（BNGO）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是Bionano Genomics, Inc.的5.6倍（$44.6M vs $8.0M）。帕可Bio净利率更高（-90.4% vs -99.8%，领先9.3%）。帕可Bio同比增速更快（13.8% vs -2.6%）。过去两年帕可Bio的营收复合增速更高（7.3% vs -4.8%）
Bionano Genomics是一家基因组技术企业，开发并销售专有光学基因组测绘技术及相关诊断解决方案，可高精度检测基因组大型结构变异，服务全球学术研究机构、生物制药企业与临床诊断实验室，产品应用于肿瘤、罕见病研究等领域。
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
BNGO vs PACB — 直观对比
营收规模更大
PACB
是对方的5.6倍
$8.0M
营收增速更快
PACB
高出16.4%
-2.6%
净利率更高
PACB
高出9.3%
-99.8%
两年增速更快
PACB
近两年复合增速
-4.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $44.6M |
| 净利润 | $-7.9M | $-40.4M |
| 毛利率 | 42.8% | 37.1% |
| 营业利润率 | -107.4% | -92.3% |
| 净利率 | -99.8% | -90.4% |
| 营收同比 | -2.6% | 13.8% |
| 净利润同比 | 60.6% | -1802.7% |
| 每股收益（稀释后） | $-0.12 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNGOPACB
| Q4 25 | $8.0M | $44.6M | ||
| Q3 25 | $7.4M | $38.4M | ||
| Q2 25 | $6.7M | $39.8M | ||
| Q1 25 | $6.5M | $37.2M | ||
| Q4 24 | $8.2M | $39.2M | ||
| Q3 24 | $6.1M | $40.0M | ||
| Q2 24 | $7.8M | $36.0M | ||
| Q1 24 | $8.8M | $38.8M |
净利润BNGOPACB
| Q4 25 | $-7.9M | $-40.4M | ||
| Q3 25 | $-8.5M | $-38.0M | ||
| Q2 25 | $-6.9M | $-41.9M | ||
| Q1 25 | $-3.1M | $-426.1M | ||
| Q4 24 | $-20.1M | $2.4M | ||
| Q3 24 | $-44.2M | $-60.7M | ||
| Q2 24 | $-16.2M | $-173.3M | ||
| Q1 24 | $-31.4M | $-78.2M |
毛利率BNGOPACB
| Q4 25 | 42.8% | 37.1% | ||
| Q3 25 | 45.7% | 41.4% | ||
| Q2 25 | 51.6% | 36.9% | ||
| Q1 25 | 45.5% | -3.7% | ||
| Q4 24 | 41.9% | 25.6% | ||
| Q3 24 | -139.1% | 25.0% | ||
| Q2 24 | 33.3% | 16.5% | ||
| Q1 24 | 32.2% | 29.1% |
营业利润率BNGOPACB
| Q4 25 | -107.4% | -92.3% | ||
| Q3 25 | -115.9% | -101.1% | ||
| Q2 25 | -115.8% | -112.8% | ||
| Q1 25 | -131.1% | -1154.5% | ||
| Q4 24 | -146.3% | -390.1% | ||
| Q3 24 | -722.9% | -160.3% | ||
| Q2 24 | -219.0% | -488.3% | ||
| Q1 24 | -354.9% | -209.6% |
净利率BNGOPACB
| Q4 25 | -99.8% | -90.4% | ||
| Q3 25 | -115.4% | -98.9% | ||
| Q2 25 | -101.8% | -105.4% | ||
| Q1 25 | -48.0% | -1146.8% | ||
| Q4 24 | -246.5% | 6.0% | ||
| Q3 24 | -728.6% | -151.9% | ||
| Q2 24 | -208.8% | -481.3% | ||
| Q1 24 | -358.3% | -201.4% |
每股收益（稀释后）BNGOPACB
| Q4 25 | $-0.12 | $-0.11 | ||
| Q3 25 | $-1.59 | $-0.13 | ||
| Q2 25 | $-1.99 | $-0.14 | ||
| Q1 25 | $-1.15 | $-1.44 | ||
| Q4 24 | $-7.05 | $-0.44 | ||
| Q3 24 | $-30.92 | $-0.22 | ||
| Q2 24 | $-14.41 | $-0.64 | ||
| Q1 24 | $-35.75 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $279.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $44.4M | $5.3M |
| 总资产 | $73.6M | $784.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BNGOPACB
| Q4 25 | $3.0M | $279.5M | ||
| Q3 25 | $3.1M | $298.7M | ||
| Q2 25 | $3.6M | $314.7M | ||
| Q1 25 | $3.6M | $343.1M | ||
| Q4 24 | $9.2M | $389.9M | ||
| Q3 24 | $8.8M | $471.1M | ||
| Q2 24 | $10.4M | $509.8M | ||
| Q1 24 | $15.8M | $561.9M |
股东权益BNGOPACB
| Q4 25 | $44.4M | $5.3M | ||
| Q3 25 | $49.8M | $36.1M | ||
| Q2 25 | $45.4M | $61.5M | ||
| Q1 25 | $48.2M | $91.6M | ||
| Q4 24 | $35.4M | $506.6M | ||
| Q3 24 | $48.9M | $453.1M | ||
| Q2 24 | $80.3M | $492.7M | ||
| Q1 24 | $82.8M | $649.0M |
总资产BNGOPACB
| Q4 25 | $73.6M | $784.1M | ||
| Q3 25 | $79.1M | $803.2M | ||
| Q2 25 | $76.0M | $825.5M | ||
| Q1 25 | $78.4M | $860.8M | ||
| Q4 24 | $76.7M | $1.3B | ||
| Q3 24 | $87.4M | $1.5B | ||
| Q2 24 | $129.4M | $1.5B | ||
| Q1 24 | $158.0M | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.9M |
| 自由现金流率自由现金流/营收 | — | -44.6% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-114.1M |
8季度趋势，按日历期对齐
经营现金流BNGOPACB
| Q4 25 | $-4.2M | $-19.1M | ||
| Q3 25 | $-5.9M | $-18.7M | ||
| Q2 25 | $-3.5M | $-29.4M | ||
| Q1 25 | $-2.8M | $-44.1M | ||
| Q4 24 | $-6.5M | $-30.6M | ||
| Q3 24 | $-13.3M | $-45.5M | ||
| Q2 24 | $-21.0M | $-54.3M | ||
| Q1 24 | $-28.1M | $-75.7M |
自由现金流BNGOPACB
| Q4 25 | — | $-19.9M | ||
| Q3 25 | — | $-18.8M | ||
| Q2 25 | — | $-29.9M | ||
| Q1 25 | — | $-45.4M | ||
| Q4 24 | — | $-32.3M | ||
| Q3 24 | — | $-46.3M | ||
| Q2 24 | — | $-55.7M | ||
| Q1 24 | — | $-79.6M |
自由现金流率BNGOPACB
| Q4 25 | — | -44.6% | ||
| Q3 25 | — | -48.9% | ||
| Q2 25 | — | -75.3% | ||
| Q1 25 | — | -122.3% | ||
| Q4 24 | — | -82.3% | ||
| Q3 24 | — | -115.7% | ||
| Q2 24 | — | -154.8% | ||
| Q1 24 | — | -205.0% |
资本支出强度BNGOPACB
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 3.7% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | 10.0% |
现金转化率BNGOPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -12.93× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNGO
暂无分部数据
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
